Cannformatics to Announce Dementia and Medical Cannabis Study at the 2nd Annual New York State Medical Cannabis Symposium
Study evaluating cannabinoids in dementia to be conducted at Northwell Health receives IRB approval; Cannformatics to present on Friday, November 7 Cannformatics Inc., a biotechnology company advancing the use of metabolic biomarkers and artificial intelligence to personalize medical cannabis treatment, today announced that a proof-of-concept study to be conducted at Northwell Health on medical cannabis […]